DMDaniela C. Marcano

Daniela C. Marcano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Daniela C. Marcano has a total of 104 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Use of a bioengineered antioxidant in mouse models of metabolic syndrome

    by Deric M. Griffin, Brittany R. Bitner, Zachary Criss Ii, Daniela Marcano, Jacob M. Berlin, Thomas A. Kent, James M. Tour, Susan L. Samson, Robia G. Pautler

    Background: Metabolic syndrome (MetS) is a group of conditions that increase the risk of developing heart disease, stroke and type-2 diabetes and is present in 35% of US adults. Oxidative stress has been implicated in MetS, however, antioxidants such as vitamin E have had limited success in the clinic. This prompts the question of what effects a more potent antioxidant might produce. A prime candidate is the recently developed bioengineered antioxidant, poly(ethylene glycol)-functionalized hydrophilic carbon clusters (PEG-HCCs), which is capable of neutralizing the reactive oxygen species (ROS) superoxide anion and hydroxyl radical at 106/molecule of PEG-HCC. Objective: To determine the potential of PEG-HCCs as a possible therapeutic for MetS. Methods: The B6.Cg-Lepob/J (ob/ob) and high-fat diet (HFD) mouse models of MetS were used. C57BL/6J mice served as wild-type (WT) controls. Mice were fed their respective diets and treated with PEG-HCCs or saline for 6-10 weeks (ob/ob and WT) or 2-5 weeks (HFD and WT) during which we assessed levels of lipid peroxidation, aminotransferase, blood glucose, insulin, and c-jun N-terminal kinase (JNK). We also assessed gluconeogenesis and inflammatory gene expression by qPCR and PEG-HCC biodistribution by immunohistochemistry. Results: PEG-HCC treatment lessened lipid peroxidation, aspartate aminotransferase levels, non-fasting blood glucose levels and JNK phosphorylation in ob/ob mice. PEG-HCC treated WT mice had an increased response to insulin by ITT and a decrease in blood glucose by GTT. These effects were not observed in HFD-fed mice, regardless of treatment. PEG-HCCs were observed in the interstitial space of liver, spleen, skeletal muscle and adipose tissue. No significant difference was shown in gluconeogenesis or inflammatory gene expression between treatment and dietary groups. Conclusions: PEG-HCC can improve some parameters of disease in these models and this may be due to a resulting increase in peripheral insulin sensitivity. However, additional studies are needed to elucidate how PEG-HCCs are producing these effects.


  • Open Access

    Nanoparticulate carbon black in cigarette smoke induces DNA cleavage and Th17-mediated emphysema

    by Ran You, Wen Lu, Ming Shan, Jacob M Berlin, Errol Lg Samuel, Daniela C Marcano, Zhengzong Sun, William Ka Sikkema, Xiaoyi Yuan, Lizhen Song, et al.

    Chronic inhalation of cigarette smoke is the major cause of sterile inflammation and pulmonary emphysema. The effect of carbon black (CB), a universal constituent of smoke derived from the incomplete combustion of organic material, in smokers and non-smokers is less known. In this study, we show that insoluble nanoparticulate carbon black (nCB) accumulates in human myeloid dendritic cells (mDCs) from emphysematous lung and in CD11c+ lung antigen presenting cells (APC) of mice exposed to smoke. Likewise, nCB intranasal administration induced emphysema in mouse lungs. Delivered by smoking or intranasally, nCB persisted indefinitely in mouse lung, activated lung APCs, and promoted T helper 17 cell differentiation through double-stranded DNA break (DSB) and ASC-mediated inflammasome assembly in phagocytes. Increasing the polarity or size of CB mitigated many adverse effects. Thus, nCB causes sterile inflammation, DSB, and emphysema and explains adverse health outcomes seen in smokers while implicating the dangers of nCB exposure in non-smokers.


  • Open Access

    The microRNA miR-22 inhibits the histone deacetylase HDAC4 to promote TH17 cell–dependent emphysema

    by Wen Lu, Ran You, Xiaoyi Yuan, Tianshu Yang, Errol L G Samuel, Daniela C Marcano, William K A Sikkema, James M Tour, Antony Rodriguez, Farrah Kheradmand, et al.

    Smoking can lead to emphysema. Corry and colleagues show that smoke and carbon black particles induce the microRNA miR-22 as a mediator that suppresses expression of the histone deacetylase HDAC4 and thereby promotes a chronic TH17 cell–dependent inflammatory response. Smoking-related emphysema is a chronic inflammatory disease driven by the TH17 subset of helper T cells through molecular mechanisms that remain obscure. Here we explored the role of the microRNA miR-22 in emphysema. We found that miR-22 was upregulated in lung myeloid dendritic cells (mDCs) of smokers with emphysema and antigen-presenting cells (APCs) of mice exposed to smoke or nanoparticulate carbon black (nCB) through a mechanism that involved the transcription factor NF-κB. Mice deficient in miR-22, but not wild-type mice, showed attenuated TH17 responses and failed to develop emphysema after exposure to smoke or nCB. We further found that miR-22 controlled the activation of APCs and TH17 responses through the activation of AP-1 transcription factor complexes and the histone deacetylase HDAC4. Thus, miR-22 is a critical regulator of both emphysema and TH17 responses.


  • Dexamethasone nanowafer as an effective therapy for dry eye disease

    by Terry G. Coursey, Johanna Tukler Henriksson, Daniela C. Marcano, Crystal S. Shin, Lucas C. Isenhart, Faheem Ahmed, Cintia S. De Paiva, Stephen C. Pflugfelder, Ghanashyam Acharya


  • The 2-Pyridylcyanoxime and its Complexes

    by Daniela C. Marcano, Sergey V. Lindeman, Monica Pyrkosz-Bulska, Elzbieta Gumienna-Kontecka, Attila Lengyel, Erno Kuzmann, Frank Rominger, Nikolay Gerasimchuk

    The preparation of 2-pyridyl cyanoxime (hereafter referred to as H(2PCO)), along with several metal complexes, is described in detail. The cyanoxime was investigated in solutions, and its two protonation constants were measured spectrophotometrically following a significant shift of the compound’s π→π* transitions at 208 and 280 nm. The first, with pK1=1.81(9), corresponds to proton release from the pyridine moiety, and the second, pK2=6.77(1), corresponds to a proton release from the hydroxyimino group. The H(2PCO) in solution easily deprotonates to form a yellow conjugated anion, which demonstrates significant solvatochromism in solutions: the bathochromic shift of n→π* band for 2PCO- in methanol (MeOH) and dimethylformamide (DFM) is 90 nm, which is one of the highest on record for cyanoximes. The crystal structures of the free ligand, H(2PCO); its ionic derivative, PPh4(2PCO); and its divalent complexes, [Ni(2PCO)2·2H2O], [Ni{2PCO}2(H2O)}2], mer-PPh4[Ni(2PCO)3]·2H2O, and mer-AsPh4[Fe(2PCO)3], were determined. The protonated cyanoxime H(2PCO) and as anion in transition metal complexes adopt cis-anti configuration and act as bidentate-chelate or tridentate (chelate + bridging mode) ligand. Data from the 57Fe Mössbauer spectroscopy indicated that the “AsPh4[Fe(2PCO)3]” sample comprised of 85-88% low-spin Fe(II) compound state with small value of the QS, and 12-15% Fe2+ compound being in high-spin state. The major component corresponds to the mer-isomer, while the high-spin component is suggested for the [Fe(2PCO)2·2H2O] complex. The formation constants in the H(2PCO) – Fe2+ system were measured using UV-visible spectroscopy and showed that the intensely colored [Fe(2PCO)3]- anionic complex (λmax=533 nm) has Kf= 11.09. This finding is the second highest established for colored iron(II) complexes after [Fe(phen)3]2+ cationic compound that is traditionally used in analytical chemistry.


  • Highly efficient conversion of superoxide to oxygen using hydrophilic carbon clusters

    by Errol L. G. Samuel, Daniela C. Marcano, Vladimir Berka, Brittany R. Bitner, Gang Wu, Austin Potter, Roderic H. Fabian, Robia G. Pautler, Thomas A. Kent, Ah-Lim Tsai, et al.

    Many diseases are associated with oxidative stress, which occurs when the production of reactive oxygen species (ROS) overwhelms the scavenging ability of an organism. Here, we evaluated the carbon nanoparticle antioxidant properties of poly(ethylene glycolated) hydrophilic carbon clusters (PEG-HCCs) by electron paramagnetic resonance (EPR) spectroscopy, oxygen electrode, and spectrophotometric assays. These carbon nanoparticles have 1 equivalent of stable radical and showed superoxide (O2•−) dismutase-like properties yet were inert to nitric oxide (NO•) as well as peroxynitrite (ONOO−). Thus, PEG-HCCs can act as selective antioxidants that do not require regeneration by enzymes. Our steady-state kinetic assay using KO2 and direct freeze-trap EPR to follow its decay removed the rate-limiting substrate provision, thus enabling determination of the remarkable intrinsic turnover numbers of O2•− to O2 by PEG-HCCs at >20,000 s−1. The major products of this catalytic turnover are O2 and H2O2, making the PEG-HCCs a biomimetic superoxide dismutase.


  • Open Access

    Ocular Drug Delivery Nanowafer with Enhanced Therapeutic Efficacy

    by Xiaoyong Yuan, Daniela C. Marcano, Crystal S. Shin, Xia Hua, Lucas C. Isenhart, Stephen C. Pflugfelder, Ghanashyam Acharya

    Presently, eye injuries are treated by topical eye drop therapy. Because of the ocular surface barriers, topical eye drops must be applied several times in a day, causing side effects such as glaucoma, cataract, and poor patient compliance. This article presents the development of a nanowafer drug delivery system in which the polymer and the drug work synergistically to elicit an enhanced therapeutic efficacy with negligible adverse immune responses. The nanowafer is a small transparent circular disc that contains arrays of drug-loaded nanoreservoirs. The slow drug release from the nanowafer increases the drug residence time on the ocular surface and its subsequent absorption into the surrounding ocular tissue. At the end of the stipulated period of drug release, the nanowafer will dissolve and fade away. The in vivo efficacy of the axitinib-loaded nanowafer was demonstrated in treating corneal neovascularization (CNV) in a murine ocular burn model. The laser scanning confocal imaging and RT-PCR study revealed that once a day administered axitinib nanowafer was therapeutically twice as effective, compared to axitinib delivered twice a day by topical eye drop therapy. The axitinib nanowafer is nontoxic and did not affect the wound healing and epithelial recovery of the ocular burn induced corneas. These results confirmed that drug release from the axitinib nanowafer is more effective in inhibiting CNV compared to the topical eye drop treatment even at a lower dosing frequency.


  • Hydrophilic carbon clusters as therapeutic, high-capacity antioxidants

    by Errol L.G. Samuel, MyLinh T. Duong, Brittany R. Bitner, Daniela C. Marcano, James M. Tour, Thomas A. Kent


  • Biocompatibility of pristine graphene for neuronal interface

    by Deshdeepak Sahni, Andrew Jea, Javier A. Mata, Daniela C. Marcano, Ahilan Sivaganesan, Jacob M. Berlin, Claudio E. Tatsui, Zhengzong Sun, Thomas G. Luerssen, Shiyun Meng, et al.

    Object: Graphene possesses unique electrical, physical, and chemical properties that may offer significant potential as a bioscaffold for neuronal regeneration after spinal cord injury. The purpose of this investigation was to establish the in vitro biocompatibility of pristine graphene for interface with primary rat cortical neurons. Methods: Graphene films were prepared by chemical vapor deposition on a copper foil catalytic substrate and subsequent apposition on bare Permanox plastic polymer dishes. Rat neuronal cell culture was grown on graphene-coated surfaces, and cell growth and attachment were compared with those on uncoated and poly-d-lysine (PDL)-coated controls; the latter surface is highly favorable for neuronal attachment and growth. Live/dead cell analysis was conducted with flow cytometry using ethidium homodimer-1 and calcein AM dyes. Lactate dehydrogenase (LDH) levels—indicative of cytotoxicity—were measured as markers of cell death. Phase contrast microscopy of active cell culture was conducted to assess neuronal attachment and morphology. Results: Statistically significant differences in the percentage of live or dead neurons were noted between graphene and PDL surfaces, as well as between the PDL-coated and bare surfaces, but there was little difference in cell viability between graphene-coated and bare surfaces. There were significantly lower LDH levels in the graphene-coated samples compared with the uncoated ones, indicating that graphene was not more cytotoxic than the bare control surface. According to phase contrast microscopy, neurons attached to the graphene-coated surface and were able to elaborate long, neuritic processes suggestive of normal neuronal metabolism and morphology. Conclusions: Further use of graphene as a bioscaffold will require surface modification that enhances hydrophilicity to increase cellular attachment and growth. Graphene is a nanomaterial that is biocompatible with neurons and may have significant biomedical applications.


  • Design of Poly(ethylene Glycol)-Functionalized Hydrophilic Carbon Clusters for Targeted Therapy of Cerebrovascular Dysfunction in Mild Traumatic Brain Injury

    by Daniela C. Marcano, Brittany R. Bitner, Jacob M. Berlin, Jane Jarjour, Juhye M. Lee, Aakash Jacob, Roderic H. Fabian, Thomas A. Kent, James M. Tour

    Traumatic brain injury (TBI) involves the elaboration of oxidative stress that causes cerebrovascular dysfunction, including impairment of autoregulation of cerebral blood flow. Currently, there is no clinically effective antioxidant treatment for these pathologies. Most currently available antioxidants act through mechanisms in which the antioxidant either transfers the radical or requires regeneration, both of which are impaired in the toxic post-TBI environment. We previously reported that single-walled carbon nanotubes (SWCNTs) and ultrashort SWCNTs possess antioxidant activity, and their characteristics suggest that radical annihilation is the major mechanism. We have now developed a biologically compatible class of carbon-based nanovectors, poly(ethylene glycol)-functionalized hydrophilic carbon clusters (PEG-HCCs) that can be further functionalized with antibodies, and hence show promise as targeted drug delivery platforms. Here we report that PEG-HCCs possess innate antioxidant activity and can be rapidly targeted via an antibody to the P-selectin antigen in a model of injured cultured brain endothelial cells. One immediate application of this therapy is to vascular dysfunction that accompanies TBI and worsens outcome in the face of systemic hypotension. These in vitro results support the need for further investigation in animal models.